Suprastin, tablets 25 mg 20 pcs

Skin itching, Allergic conjunctivitis, Allergic rhinitis, Eczema, Insect bites, Dermatitis, Pollinosis, Urticaria, Neurodermitis, Allergy

• Allergic diseases (incl. urticaria, serum sickness, pollinosis, or hay fever, rhinitis, conjunctivitis);

• anaphylactic shock and angioedema; skin diseases (including

• Prevention and treatment of allergic and pseudoallergic reactions to medications and diagnostic preparations; itching and insect bites; SARS.

.

Indications

Allergic diseases (including urticaria, serum sickness, hay fever, rhinitis, conjunctivitis);

anaphylactic shock and angioedema; skin diseases (including contact dermatitis, acute and chronic eczema, neurodermatitis, toxicoderma);

prevention and treatment of allergic and pseudoallergic reactions to drugs and diagnostic drugs; itching and insect bites; ARVI.

Pharmacological effect

Antiallergic agent – H1-histamine receptor blocker.

ATX Code:

Special instructions

The drug should be used with caution in elderly patients, with insufficient liver function and/or heart disease. The drug should be prescribed orally with extreme caution in case of angle-closure glaucoma, in patients with urinary retention and prostatic hypertrophy.

When taken at night, the drug may increase the symptoms of reflux esophagitis.

Suprastin should be prescribed with caution simultaneously with sedatives, tranquilizers, analgesics, MAO inhibitors, tricyclic antidepressants, atropine and/or sympatholytics.

During treatment, the consumption of alcoholic beverages should be avoided.

Impact on the ability to drive vehicles and operate machinery

During the initial, individually determined period of use of Suprastin, driving vehicles and engaging in other potentially hazardous activities that require rapid psychomotor reactions are not allowed.

In the process of further treatment, the degree of restrictions is determined depending on the individual tolerability of the drug.

Active ingredient

Chloropyramine

Composition

1 tablet contains chloropyramine hydrochloride 25 mg;

excipients:

lactose,

starch,

talc,

sodium amylopectin,

gelatin,

stearic acid.

Pregnancy

Pregnancy
There have been no adequate controlled clinical studies of the use of antihistamines in pregnant women. However, cases of retrolental fibroplasia have been described in newborns whose mothers took antihistamines in the last months of pregnancy. Accordingly, the use of Suprastin® during pregnancy is contraindicated.

Breastfeeding
The use of Suprastin® is contraindicated during breastfeeding.
If it is necessary to use the drug during lactation, breastfeeding should be stopped.

Contraindications

Hypersensitivity to the components of the drug;
acute attack of bronchial asthma;
children under 3 years of age (for this dosage form);
lactase deficiency, lactose intolerance, glucose/galactose malabsorption (since the tablet contains 116 mg of lactose monohydrate);
pregnancy;
lactation period.

With caution: angle-closure glaucoma; urinary retention; prostatic hyperplasia; liver and/or kidney dysfunction; cardiovascular diseases; elderly patients.

Side Effects

From the side of the central nervous system: lethargy, drowsiness, weakness, mild tremor, dizziness are possible. In children, there may be some stimulating effect on the central nervous system, manifested by anxiety, increased irritability, and insomnia.

From the digestive system: dry mouth, nausea, vomiting, diarrhea or constipation are possible.

From the cardiovascular system: rarely – decreased blood pressure (more often in elderly patients), tachycardia, arrhythmia.

Allergic reactions: possible skin rash, itching.

Other: rarely – difficulty urinating.

Interaction

With simultaneous use, Suprastin enhances the effects of anesthesia, hypnotics, tranquilizers, analgesics, MAO inhibitors, tricyclic antidepressants, atropine and sympatholytics.

With the simultaneous use of Suprastin and caffeine or phenamine, a decrease or elimination of the inhibitory effect of Suprastin on the central nervous system is observed.

Overdose

Symptoms similar to those of atropine intoxication may appear.

Treatment:
There are no specific antidotes, so symptomatic treatment is carried out.

For up to 12 hours after taking Suprastin, gastric lavage is necessary (it should be taken into account that gastric emptying is prevented by the anticholinergic effect of the drug). The use of activated carbon is also indicated.

Monitoring of blood pressure and breathing parameters is necessary.

Storage conditions

At room temperature

Shelf life

5 years

Manufacturer

EGIS, Hungary